Sign in
MENS Stock Price, Chart, Stats & News
Jyong Biotech Ltd. Ordinary Shares
Save
Jyong Biotech Ltd. Ordinary Shares (MENS) does not currently pay a dividend.
141.41M
Market cap
–
Current P/E
–
Forward P/E
MENS chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -3.33% |
ROE | 3.94% |
D/E | -1.57x |
Interest coverage ratio | -1.96x |
MENS valuation
P/E | – |
P/S | – |
P/B | -6.19x |
P/CF | -163584.63x |
P/FCF | -173318.07x |
P/OCF | -163584.63x |
PEG | -1.11x |
EV multiple | -134.48x |
About
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidates, which notably features MCS-2, currently undergoing Phase III trials for benign prostatic hyperplasia (BPH); PCP, which is in Phase II development for prostate cancer; and IC, presently in pre-clinical stages.
Similar securities
Based on sector and market capitalization
Report issue